Cart
sales@molnova.com
CTB
CAS No. 451491-47-7
CTB ( Cholera Toxin B subunit )
Catalog No. M28749 CAS No. 451491-47-7
CTB (Cholera Toxin B subunit) is an activator of p300 histone acetyltransferase and induces apoptosis in MCF-7 cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 53 | Get Quote |
|
| 10MG | 87 | Get Quote |
|
| 25MG | 178 | Get Quote |
|
| 50MG | 295 | Get Quote |
|
| 100MG | 475 | Get Quote |
|
| 500MG | 1017 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCTB
-
NoteResearch use only, not for human use.
-
Brief DescriptionCTB (Cholera Toxin B subunit) is an activator of p300 histone acetyltransferase and induces apoptosis in MCF-7 cells.
-
DescriptionCTB (Cholera Toxin B subunit) is an activator of p300 histone acetyltransferase and induces apoptosis in MCF-7 cells.(In Vitro):dose-dependent.
-
SynonymsCholera Toxin B subunit
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
RecptorD2 receptor;5-HT2A
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number451491-47-7
-
Formula Weight686.5
-
Molecular FormulaC32H25Cl2F6N2O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCOc(cccc1)c1C(Nc(cc1)cc(C(F)(F)F)c1Cl)=OCCOc(cccc1)c1C(Nc(cc1)cc(C(F)(F)F)c1Cl)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Schotte A, et al. In vitro receptor binding and in vivo receptor occupancy in rat and guinea pig brain: risperidone compared with antipsychotics hitherto used. Jpn J Pharmacol. 1995 Dec;69(4):399-412.
molnova catalog
related products
-
dCBP-1
dCBP-1 is a chemical degrader of p300/CBP. dCBP-1 hijacks the E3 ubiquitin ligase CRBN for selective degradation of p300/CBP. Degradation of p300/CBP by dCBP-1 leads to effective multiple myeloma cell killing.
-
XD14
XD14 is an inhibitor of BET bromodomain (Kd of 160 nM, 170 nM, 380 nM, 490 nM, 830 nM and 850 nM for BRD4(1), BRD2(1), BRD3(1), BRD3(2), BRD2(2) and BRD4(2), respectively).
-
Menin-MLL inhibitor ...
Menin-MLL inhibitor 20 is an irreversible menin-MLL interaction inhibitor with antitumor activities (WO2020142557A1, compound 6).
